Clinical and economic burden of infections in hospitalized solid organ transplant recipients compared with the general population in Canada – a retrospective cohort study

Summary Infections continue to be a major cause of post‐transplant morbidity and mortality, requiring increased health services utilization. Estimates on the magnitude of this impact are relatively unknown. Using national administrative databases, we compared mortality, acute care health services utilization, and costs in solid organ transplant ( SOT ) recipients to nontransplant patients using a retrospective cohort of hospitalizations in Canada (excluding Manitoba/Quebec) between April‐2009 and March‐2014, with a diagnosis of pneumonia, urinary tract infection ( UTI ), or sepsis. Costs were analyzed using multivariable linear regression. We examined 816 324 admissions in total: 408 352 pneumonia; 328 066 UTI 's; and 128 275 sepsis. Unadjusted mean costs were greater in SOT compared to non‐ SOT patients with pneumonia [(C$14 923 ± C$29 147) vs. (C$11 274 ± C$18 284)] and sepsis [(C$23 434 ± C$39 685) vs. (C$20 849 ± C$36 257)]. Mortality (7.6% vs. 12.5%; P  < 0.001), long‐term care transfer (5.3% vs. 16.5%; P  < 0.001), and mean length of stay (11.0 ± 17.7 days vs. 13.1 ± 24.9 days; P  < 0.001) were lower in SOT . More SOT patients could be discharged home (63.2% vs. 44.3%; P  < 0.001), but required more specialized care (23.5% vs. 16.1%; P  < 0.001). Adjusting for age and comorbidities, hospitalization costs for SOT patients were 10% (95% CI : 8–12%) lower compared to non‐ SOT patients. Increased absolute hospitalization costs for these infections are tempered by lower adjusted costs and favorable clinical outcomes.